<DOC>
	<DOCNO>NCT00091559</DOCNO>
	<brief_summary>A study patient diagnose advanced cutaneous T-cell lymphoma ( stage 1B high ) progressive , persistent , recurrent disease follow 2 therapy , one must contain Targretin ( bexarotene ) patient candidate could tolerate Targretin therapy .</brief_summary>
	<brief_title>Oral SAHA ( Suberoylanilide Hydroxamic Acid ) Advanced Cutaneous T-cell Lymphoma ( 0683-001 )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Vorinostat</mesh_term>
	<criteria>Patients Cutaneous Tcell Lymphoma ( Stage 1B high ) Age : 18 year age Have ability swallow capsule . You must least 3 week prior chemotherapy anticancer therapy treatment recover side effect treatment . Patients also require adequate heart , liver , kidney function . Pregnant nursing woman know allergy study drug exclude study . Patients exclude currently receive chemotherapy , radiation therapy , investigational anticancer therapy . Patients diagnose HIV , active hepatitis require intravenous antibiotic antifungal agent permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>CTCL</keyword>
</DOC>